Interim report of the Committee on Geographic Variation in Health Care Spending and Promotion of High-Value Care : preliminary committee observations / Committee on Geographic Variation in Health Care Spending and Promotion of High-Value Care, Board on Health Care Services ; Joseph P. Newhouse [and five others], editors ; Institute of Medicine of the National Academies.

By:

Institute of Medicine (U.S.). Committee on Geographic Variation in Health Care Spending and Promotion of High-Value Care [author.]

Contributor(s):

Material type: Text

TextPublisher: Washington, District of Columbia : National Academies Press, [2013]Copyright date: ©2013Description: 1 online resource (53 pages) : illustrations (some color), maps (some color)Content type:

text

Media type:

computer

Carrier type:

online resource

ISBN:

9780309282833
0309282837
0309282853
9780309282857

Subject(s): Genre/Form:

Additional physical formats: Print version:: Interim report of the Committee on Geographic Variation in Health Care Spending and Promotion of High-Value Care : preliminary committee observations.DDC classification:

368.42600973 22

LOC classification:

RA412.3 .I572 2013eb

NLM classification:

WT 31

Online resources:

Click here to access online

Contents:

Research framework and statistical modeling approach -- Geography and indexing value -- Evaluation of a geographic value index -- Contributors to geographic variation in Medicare spending -- Discussion -- Limitations.

Summary: "Interim Report of the Committee on Geographic Variation in Health Care Spending and Promotion of High-Value Health Care: Preliminary Committee Observations is designed to provide the committee's preliminary observations for the 113th Congress as it considers further Medicare reform. This report contains only key preliminary observations related primarily to the committee's commissioned analyses of Medicare Parts A (Hospital Insurance program), B (Supplementary Medical Insurance program) and D (outpatient prescription drug benefit), complemented by other empirical investigations. It does not contain any observations related to the committee's commissioned analyses of the commercial insurer population, Medicare Advantage, or Medicaid, which will be presented in the committee's final report after completion of quality-control activities. This interim report excludes conclusions or recommendations related to the committee's consideration of the geographic value index or other payment reforms designed to promote high value care. Additional analyses are forthcoming, which will influence the committee's deliberations. These analyses include an exploration of how Medicare Part C (Medicare Advantage) and commercial spending, utilization, and quality vary compared with, and possibly are influenced by, Medicare Parts A and B spending, utilization, and quality. The committee also is assessing potential biases that may be inherent to Medicare and commercial claims-based measures of health status. Based on this new evidence and continued review of the literature, the committee will confirm the accuracy of the observations presented in this interim report and develop final conclusions and recommendations, which will be published in the committee's final report"--Publisher's description

Item type:

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Home library	Collection	Call number	Materials specified	Status	Date due	Barcode
Electronic-Books	OPJGU Sonepat- Campus	E-Books EBSCO			Available

Errata sheet inserted.

Includes bibliographical references (pages 31-34).

"Interim Report of the Committee on Geographic Variation in Health Care Spending and Promotion of High-Value Health Care: Preliminary Committee Observations is designed to provide the committee's preliminary observations for the 113th Congress as it considers further Medicare reform. This report contains only key preliminary observations related primarily to the committee's commissioned analyses of Medicare Parts A (Hospital Insurance program), B (Supplementary Medical Insurance program) and D (outpatient prescription drug benefit), complemented by other empirical investigations. It does not contain any observations related to the committee's commissioned analyses of the commercial insurer population, Medicare Advantage, or Medicaid, which will be presented in the committee's final report after completion of quality-control activities. This interim report excludes conclusions or recommendations related to the committee's consideration of the geographic value index or other payment reforms designed to promote high value care. Additional analyses are forthcoming, which will influence the committee's deliberations. These analyses include an exploration of how Medicare Part C (Medicare Advantage) and commercial spending, utilization, and quality vary compared with, and possibly are influenced by, Medicare Parts A and B spending, utilization, and quality. The committee also is assessing potential biases that may be inherent to Medicare and commercial claims-based measures of health status. Based on this new evidence and continued review of the literature, the committee will confirm the accuracy of the observations presented in this interim report and develop final conclusions and recommendations, which will be published in the committee's final report"--Publisher's description